Amgen's Partnering Priorities
Amgen Business Development is committed to partnering with innovators in the fight against serious illnesses. Our Business Development team brings together deep scientific, financial, deal, partnership, and integration expertise—along with an ability to bring the right people inside Amgen to the right conversations. Business development plays a critical role in the execution of Amgen’s growth strategy. From the early-stage innovations we fund through Amgen Ventures, to the integration and Alliance Management work we engage in once an agreement is reached, Amgen Business Development is organized to effectively manage the process of working with partners every step of the way.
Rachna Khosla
SVP Business Development
“We are committed to advancing the best innovation to transform patients’ lives – whether it’s internally or externally sourced. Sponsoring and attending BIO allows our Business Development team to start important conversations and strengthen relationships toward that goal. Contact us to talk about how we can harness the power of partnership to change lives together.”
Log in to BIO Partnering™ to send us a meeting request.
External R&D
Erin Denny
Executive Director, Business Development, Oncology & Inflammation
Helen Kim
Executive Director, Business Development, Early Innovation & Academic Licensing
Amanda Mason
Executive Director, Business Development, General Medicine & Obesity
Mark Stead
Executive Director, Business Development, Technology Innovation
External R&D
Meera Bhanu Kolayarattil
Director, Business Development, Inflammation
Duncan Huston-Paterson
Director, Business Development, Early Innovation
Tony Kang
Director, Business Development, Technology Licensing
Alex Turner
Director, Business Development, Rare Disease
External R&D
Elizabeth Watt
Director, Business Development, General Medicine & Obesity
Agustin Bellosi
Senior Manager, Business Development, Rare Disease
Hugh Bender
Senior Manager, Business Development, Oncology
Matt Harms
Senior Manager, Business Development, General Medicine
External R&D
Eunice Ng
Manager, Business Development, Rare Disease
Lisa Rutledge
Manager, Business Development, Early Innovation
Transactions
Sahaj Madhav
Executive Director, Business Development, Transactions
Anita Anburajan
Director, Business Development
Nikita Jaipuria
Director, Business Development
Steven Saheb
Director, Business Development
